SYF
71
-3
COST
54
4
PH
57
4
AIV
44
-3
NI
65
9
LLY
37
4
HPE
40
-2
UPS
61
5
BSX
73
4
AON
36
4
CLX
68
2
NRG
35
3
ZTS
34
5
EXPD
23
2
TRV
42
2
PCG
58
-8
AMT
28
3
SIG
38
-3
ALL
43
6
TROW
37
5
SYF
71
-3
COST
54
4
PH
57
4
AIV
44
-3
NI
65
9
LLY
37
4
HPE
40
-2
UPS
61
5
BSX
73
4
AON
36
4
CLX
68
2
NRG
35
3
ZTS
34
5
EXPD
23
2
TRV
42
2
PCG
58
-8
AMT
28
3
SIG
38
-3
ALL
43
6
TROW
37
5
Financhill
Back

Guggenheim Strategic Opportunities Fund Vs. Janux Therapeutics Industry Stock Comparison

Buy
68

GOF
Guggenheim Strategic Opportunities Fund

Last Price:
$15.30
Seasonality Move:
1.08%
Sell
23

JANX
Janux Therapeutics

Last Price:
$50.53
Seasonality Move:
80.32%
Buy
68
Guggenheim Strategic Opportunities Fund (GOF) is a Buy

Is Guggenheim Strategic Opportunities Fund a Buy, Sell or Hold?

  • The current Guggenheim Strategic Opportunities Fund [GOF] share price is $15.32. The Score for GOF is 68, which is 36% above its historic median score of 50, and infers lower risk than normal.
  • GOF is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
23
Janux Therapeutics (JANX) is a Sell

Is Janux Therapeutics a Buy, Sell or Hold?

  • The current Janux Therapeutics [JANX] share price is $50.82. The Score for JANX is 23, which is 54% below its historic median score of 50, and infers higher risk than normal.
  • JANX is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

GOF Stock Price Chart

What is Guggenheim Strategic Opportunities Fund's stock price today?

  • The Guggenheim Strategic Opportunities Fund share price today is $15.32
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and GOF is experiencing slight buying pressure.

JANX Stock Price Chart

What is Janux Therapeutics's stock price today?

  • The Janux Therapeutics share price today is $50.82
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and JANX is experiencing selling pressure, which indicates risk of future bearish movement.

GOF Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.09 Sell
Relative Strength Index (14 RSI): 43.97 Sell
Chaikin Money Flow: 166553 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (15.19 - 15.75) Sell
Bollinger Bands (100): (15.36 - 15.86) Sell

JANX Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.52 Sell
Relative Strength Index (14 RSI): 41.88 Sell
Chaikin Money Flow: -1994706 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (53.74 - 62.68) Sell
Bollinger Bands (100): (44.76 - 56.7) Buy

GOF Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 15.34 Sell
20-day SMA: 15.36 Sell
50-day SMA: 15.63 Sell
200-day SMA: 15.2 Buy
8-day EMA: 15.35 Sell
20-day EMA: 15.41 Sell
50-day EMA: 15.53 Sell
200-day EMA: 15.27 Buy

JANX Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 53.68 Sell
20-day SMA: 56.78 Sell
50-day SMA: 54.64 Sell
200-day SMA: 47.7 Buy
8-day EMA: 54.12 Sell
20-day EMA: 55.17 Sell
50-day EMA: 54.12 Sell
200-day EMA: 45.19 Buy

Guggenheim Strategic Opportunities Fund Earnings Growth & GOF Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Janux Therapeutics Earnings Growth & JANX Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.27 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.92 per share, and a decrease next year of $0.75 per share.

Guggenheim Strategic Opportunities Fund Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Janux Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):